Hematopoietic stem cell transplantation for severe Crohn's disease

Bone Marrow Transplantation

Volumn 32, Issue , 2003, Pages S57-S59

  Craig, R M ^a   Traynor, A ^a   Oyama, Y ^a   Burt, R K ^a  

^a NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autologous stem cell transplantation; Crohn s disease; Hematopoietic stem cell transplantation

Indexed keywords

AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROMORPHONE; INFLIXIMAB; METRONIDAZOLE; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALAZOSULFAPYRIDINE; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ABDOMINAL PAIN; ARTICLE; AUTOTRANSPLANTATION; CASE REPORT; COLITIS; COLON CROHN DISEASE; COLON RADIOGRAPHY; COLONOSCOPY; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LONG TERM CARE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; TREATMENT FAILURE;

ABDOMINAL PAIN; ADULT; CROHN DISEASE; DIARRHEA; FEMALE; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; REMISSION INDUCTION; SALVAGE THERAPY; SEVERITY OF ILLNESS INDEX;

EID: 0042412496     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703945     Document Type: Article

References (23)

1. Rao SS, Cann PA, Holdsworth CD. Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulfasalazine. Scand J Gastroenterol 1987; 22: 332-336.
2. Summers RW, Switz DM, Sessions Jr JT et al. National Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 1979; 77: 847-869.
3. Bar-Meir S, Chowers Y, Lavy A et al. Budesonide versus prednisone in the treatment of active Crohn's disease. Gastroenterology 1998; 115: 835-840.
4. Willoughby JM, Becket J, Kumar PJ, Dawson JM. Controlled trial of azathioprine in Crohn's disease. Lancet 1971; 2: 944-947.
5. Present DH, Korelitz BI, Wisch N et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980; 302: 981-987.
6. Markowitz J, Grancher K, Kohn N et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119: 895-902.
7. Brynshov J, Freund L, Rasmussen SN et al. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989; 321: 845-850.
8. Kozarek RA, Patterson DJ, Gelfand MD et al. Methotrexa te induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989; 110: 353-356.
9. Neurath MF, Wanitschke R, Peters M et al. Randomized trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease. Gut 1999; 44: 625-628.
10. Targan S, Hanauer SB, van Deventer SJH et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn's disease. N Engl J Med 1997; 337: 1029-1035.
11. Present DP, Rutgeerts P, Targan S et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398-1405.
12. Fedorak RN, Gangl A, Elson CO et al. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. Gastroenterology 2000; 119: 1473-1482.
13. Bernstein LH, Frank MS, Brant LJ, Boley SJ. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980; 79: 357-365.
14. Farmer RG, Hawk WA, Turnbull RB. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 1975; 68: 627-639.
15. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship of the clinical pattern and prognosis. Gastroenterology 1985; 88: 1818-1827.
16. Lapidus A, Bernell O, Hellers G, Lofberg R. Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology 1998; 114: 1151-1160.
17. Loftus EV, Silverstein MD, Sandborn WJ et al. Crohn's disease in Olmsted county, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998; 114: 1161-1168.
18. Lopez-Cubera SO, Sullivan KM, McDonald GB. Course of Crohn's disease after allogeneic bone marrow transplantation. Gastroenterology 1998; 114: 433-440.
19. Drakos PE, Nagler A, Or R. Case of Crohn's disease in bone marrow transplantation. Am J Hematol 1993; 43: 157-158.
20. Kashyap A, Foreman SJ. Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long term remission of coincidental Crohn's disease. Br J Haematol 1998; 103: 651-652.
21. Castro J, Benich HI, Smith HL. Prolonged clinical remission in patients with inflammatory bowel disease after high dose chemotherapy and autologous bone marrow stem cell transplantation. Blood 1996; 88: 133A.
22. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 843-850.
23. Burt RK, Traynor AE, Oyama Y, Craig R. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn's Disease. Blood 2003; 101: 2064-2066.